Spear Pharmaceuticals
http://www.spearpharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Spear Pharmaceuticals
ANDAs Showing Steady Improvement In First-Cycle Approval Times
First-cycle approvals took longer than multi-cycle approvals in the generic drug user fee program's first year, but decreased dramatically in year two.
FDA Approves Its First ‘Clocked’ ANDA
Application for an acne medication is first to be approved with a formal review goal under GDUFA, and comes five months early.
Deals Shaping The Medical Industry, July-August 2012
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
-
- Spear Pharmaceuticals Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice